Nucala (mepolizumab) for the Treatment of Hypereosinophilic Syndrome (HES)

Nucala (mepolizumab) is a biologic drug used for the treatment of hypereosinophilic syndrome (HES). Credit: GlaxoSmithKline.



  • Nucala (mepolizumab)
  • Nucala (mepolizumab)
  • Nucala (mepolizumab)